STRATEC Biomedical AG 

21.12.2012 20:06

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us pursuant to sec. 21 para. 1 WpHG on 18 December 2012, that on 17 December 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.999% (586,777 voting rights).

Ameriprise Financial, Inc. has notified us that these voting rights of 4.999% (586,777 voting rights) are attributable to Ameriprise Financial, Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Ameriprise Financial, Inc. inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


21.12.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---